The Effect of Interoperable Health IT on Efficiency in Ambulatory Practices (HEAL5)

This study has been completed.
Sponsor:
Collaborators:
State University of New York at Buffalo
Weill Medical College of Cornell University
Information provided by (Responsible Party):
University of Rochester
ClinicalTrials.gov Identifier:
NCT01773577
First received: August 2, 2011
Last updated: January 17, 2013
Last verified: March 2012
  Purpose

Goal: To evaluate the effects of Interoperable Health IT on provider work flow and work practices in the ambulatory care setting.

Interoperable health IT can produce a reduction of barriers in the exchange of health information that can allow for more efficient, timely, and a higher quality of patient care. This study seeks to evaluate the effects of the implementation of interoperable health IT on the work flow of medical providers in the care environments in which they are implemented.


Condition
Operations Research Workflow

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Effect of Interoperable Health IT on Efficiency in Ambulatory Practices

Further study details as provided by University of Rochester:

Primary Outcome Measures:
  • Change in workflow pattern [ Time Frame: Day 1 ] [ Designated as safety issue: No ]

Enrollment: 53
Study Start Date: January 2010
Study Completion Date: August 2011
Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Physician Pract. Employee and Off. Staff
The office staff and providers and physician practices enrolled in the RHIO

Detailed Description:

Interoperable health IT allows for the reduction of barriers in the exchange of health information. Substantial work flow efficiencies and cost reductions may be realized by reducing these barriers, and integrating information exchange among different providers and healthcare systems. Some of the avenues in which these efficiencies and cost reductions are likely to be achieved are through easier access to test results, reduction in medication errors, quality monitoring and improvement methodologies, and increased consumer choice. In recognition of the potential for these improvements, New York State has provided funding to regional entities (Regional Health Information Organizations—RHIO'S) whose role is to assist practice providers in the development, implementation, and integration of these interoperable IT systems. New York State has also provided funding to evaluate the technology implementations facilitated by the RHIOs. The investigators will be working with health care providers that have been assisted by the Greater Rochester RHIO.

Depending on the unique characteristics of the hardware and software that is developed and implemented, there may be variations in operational flow that effect efficiency in the ambulatory care setting. The goal of our study is to measure and evaluate the effects of interoperable IT systems in the work flow practices of providers that have implemented them in the ambulatory care setting.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Primary care and primary care specialty practices participating in EHR/VHR in the Rochester Regional Health Information Organization

Criteria

Inclusion Criteria:

  • Our population will include all of the providers and office workers within the ambulatory care settings that have implemented the interoperable IT programs, and are required to utilize the systems for their daily job functions. Our research population will not include patients, as the participants of our study are the health care workers.

Exclusion Criteria:

  • Our population will be "all inclusive" of all office staff and providers that are required to utilize the systems in place in order to perform their day-to-day functions. There will be no exclusions except for those under 18 years of age, and non English speakers (neither of which are expected to be in the eligible population).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01773577

Locations
United States, New York
University of Rochester
Rochester, New York, United States, 14642
Sponsors and Collaborators
University of Rochester
State University of New York at Buffalo
Weill Medical College of Cornell University
Investigators
Principal Investigator: Peter W Crane, MD, MBA University of Rochester
  More Information

No publications provided

Responsible Party: University of Rochester
ClinicalTrials.gov Identifier: NCT01773577     History of Changes
Other Study ID Numbers: HITEC/HEAL5
Study First Received: August 2, 2011
Last Updated: January 17, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Rochester:
EHR
VHR
Electronic Health Record

ClinicalTrials.gov processed this record on August 21, 2014